- Home
- Professionals
- Residency Programs and Fellowships
- Pharmacy Residency
- Oncology Pharmacy Residency

Our vendor, Nuance Communications, Inc., was impacted by the Progress Software security incident which affected certain individuals’ personal information. Learn more.
The University of Kansas Health System offers an ASHP-accredited PGY2 Oncology Pharmacy Residency. The University of Kansas Hospital is an academic teaching hospital with 1,000+ beds, and 116 of those are dedicated to hematology, oncology and bone marrow transplant patients. The University of Kansas Cancer Center is designated as a comprehensive cancer center by the National Cancer Institute (NCI) and has 2,600+ outpatient cancer care visits weekly. This residency centers on the development of pharmacists who will become dynamic patient advocates who collaborate with an interdisciplinary team to provide evidence-based pharmacotherapy and heighten patient-centered results. Through various clinical, practice management and project experiences, residents will become competent at providing optimal drug therapy for patients with cancer and act as a leader in advancing patient care.
Length of program: 12 months, starting in July
Number of positions: 4
Hometown: Plano, Texas
Pharmacy school: UT Austin College of Pharmacy
PGY1: University of Illinois - Chicago
Clinical interests: Still exploring all the areas, but solid tumors (Breast, GI/GU, HNL) do have a special place in my heart.
Hobbies: Cooking, dance and cardio kickboxing, and exploring new restaurants with my coresidents
Research project: Determination and comparison of patient comprehension after common internet-based, cancer treatment education modalities used during chemotherapy counseling
Why I chose The University of Kansas Health System: I was drawn by the variety of experiences the program has to offer, along with the multitude of resources they provide for residents. We have the opportunity to learn from 50+ oncology pharmacists who really do value growing your knowledge and your ability to practice clinically.
The University of Kansas Cancer Center is 1 of only 54 National Cancer Institute-designated comprehensive cancer centers.
Additional facts about the cancer center include:
The specialty residency in hematology/oncology is tailored to the interests and career goals of each resident. A variety of practice settings is available. Required rotations are listed below:
Any of the required rotations may be repeated as elective rotations. Rotations will last 4-6 weeks unless approved by the residency director.
Elective rotations are designed to provide training in areas of interest. Examples of the options available include:
The PGY2 oncology resident will staff 1 weekday evening in the inpatient Cambridge Tower A pharmacy beginning in August and work every 4th weekend (Saturday and Sunday), staffing independently with the hematology inpatient rounding service.
National matching services (NMS) code: 618660
We are an equal employment opportunity employer without regard to a person’s race, color, religion, sex (including pregnancy, gender identity and sexual orientation), national origin, ancestry, age (40 or older), disability, veteran status or genetic information.
We are an equal employment opportunity employer without regard to a person’s race, color, religion, sex (including pregnancy, gender identity and sexual orientation), national origin, ancestry, age (40 or older), disability, veteran status or genetic information.